¼ÓÈëVIP ÉÏ´«¿¼²©×ÊÁÏ ÄúµÄÁ÷Á¿ Ôö¼ÓÁ÷Á¿ ¿¼²©±¨°à ÿÈÕÇ©µ½
   
Ö÷Ìâ : Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(רҵ»ù´¡: ÃâÒßѧ)
¼¶±ð: ×ܰæÖ÷
ÏÔʾÓû§ÐÅÏ¢ 
Â¥Ö÷  ·¢±íÓÚ: 2007-01-25   

Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(רҵ»ù´¡: ÃâÒßѧ)

Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ B<0lif|  
!PQ@"L)p  
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© cFH,fj  
d}WAP m  
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© ;zh|*F>  
lI&0 V5  
1.Co-stimulators (or co-stimulating molecules) F] ~`57  
uvm=i .  
2.NK-kB ^KlMBKWyB  
v,2{Vr  
3.Immunoglobulin superfamily {v2Q7ZO-  
nQ/El&{  
4.antigen-presenting cell (APC) .m+KXlP  
ggbew6L$Z  
5.death domain ^WUF3Q**OU  
J#JZ^59lOS  
6.CCR and CXCR %=_ Iq\lC  
5[;p<GqGN  
7.Lectin (or mitogen) &&t4G}*  
&z,w0FOre  
8.Clusters of differentiation, CD) M%6{A+(  
B8C"i%8V)  
9.B7 family 1?mQ fW@G  
c%v%U &  
10.Cytotoxic T lymphocyte, CTL)  LqU]&AAh  
Z*kg= hs^  
11.IL-15 and IL-15 receptor (IL-15R) JLs7[W)O  
FIW*N r  
12.MHC restriction Ag}>gbz~G  
W;,Jte<'Nm  
13.Affinity-chromatography } Z%*gfp  
<5q:mG88  
14.Cyctosprin A, CsA U3p=H^MB.  
x?f3XEA_  
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) ?p6+?\H  
x'n J _0  
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© PcJ,Y\"[  
m"jqHGFV  
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 %*:-4K  
ud! iy  
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ lq+FH&  
,AACE7%l  
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹Ô­µÄÌØµã¡£ 8 =J6{{E  
/Nb&e  
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© H| Q)Tp Lk  
v#=-  
ÃâÒßѧרҵ£º R.+Q K6B&  
;M\H#%G.  
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ QH#|R92:  
qnru atA  
Ïû»¯ÄÚ¿Æ£º Z2hRTJJ[A  
(CO8t~J=  
2.Ö×Áö¿¹Ô­·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ ; l+3l ez  
6z!?U:bT  
ѪҺ²¡Ñ§×¨Òµ£º LlX 7g _!  
gb8nST$r  
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔ­Òò£¨Ìõ¼þ£©ÊÇʲô£¿
ÆÀ¼ÛÒ»ÏÂÄãä¯ÀÀ´ËÌû×ӵĸÐÊÜ

¾«²Ê

¸Ð¶¯

¸ãЦ

¿ªÐÄ

·ßÅ­

ÎÞÁÄ

¹àË®

  
ÃèÊö
¿ìËٻظ´

ÑéÖ¤ÎÊÌâ:
5+2=? ÕýÈ·´ð°¸:7
°´"Ctrl+Enter"Ö±½ÓÌá½»